SHH:600223

Lushang Freda Pharmaceutical Co.,Ltd. · SHH · Real Estate · CNY · FY for 2025

Figures on this page computed 2026-11-08 13:37 UTC

Last close

n/aCNY

Market data

29.6xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed
- Computed from the filing for 2025
9.7%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
5.2%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
6.3%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.04Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
1.1%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed

What it pays out is the furthest below its sector's middle: 0.47 against 0.84 on the market's range.

All from 100

lens 2 of 9

Sales

47.4

2016-12-31 to 2025-12-31100 at the start47.4

Sales: 100.00 on 2016-12-31 to 47.42 on 2025-12-31, down 53%.

Profit

203

2016-12-31 to 2025-12-31100 at the start203

Profit: 100.00 on 2016-12-31 to 203.26 on 2025-12-31, up 103%.

Shares in issue

99.0

2016-12-31 to 2025-12-31100 at the start99.0

Shares in issue: 100.00 on 2016-12-31 to 99.05 on 2025-12-31, down 1%.

Sales is at 47, Profit is at 203, Shares in issue is at 99, against 100 in 2016.

Sales is at 47, Profit is at 203, Shares in issue is at 99, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 10047
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Profit, where the first year is 100203
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Shares in issue, where the first year is 10099
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY